Fami vs Famnly

Fami combines shared family scheduling with chores, budgeting, meal planning, shopping lists, and saved places. Its calendar offers day, week, month, and agenda views, color-codes events by family member, and supports recurring events. Families can import an existing Google Calendar and export events to a device calendar. Chores can be assigned by person, day, or rotation; completed chores can earn rewards, and the site says allowance is credited automatically. The AI meal planner suggests meals based on household needs and can add planned meals to the shared shopping list. Kid Mode shows children their chores, rewards, and allowance balance without the household budget or family calendar. Fami is available on Android, iOS, and the web. The free plan includes a shared calendar, chores, shopping list, budget, and family places. Premium costs $4.99 a month or $44.99 a year; both paid plans add AI meal suggestions and advanced task tools, and the annual plan includes a 7-day free trial. Fami says it does not sell personal data, and users can request data deletion through the app.

Famnly is an iOS shared family calendar that organizes family members, pets, and places in color-coded columns. It offers flow and compact week layouts as well as day, month, and year views. Sidekick turns push-to-talk voice input into event drafts with dates, assignees, and reminders. Pro adds two-way sync with Google Calendar, Outlook, Apple Calendar, and ICS feeds. Shared planning tools include grocery lists, AI meal planning, chore tracking with rewards and allowance, and a visual vacation planner. The app can use AI to read a photographed school timetable and create term events on a child's calendar. Pro supports up to three calendar groups, which can be used for a household and a shared co-parenting schedule. The Free plan costs nothing, billed Free forever, and includes one managed member. Famnly Pro costs $5.99 a month, and a seven-day trial is listed. The FAQ says the app is available for iPhone and iPad, while Android is on the roadmap.